text: W.Va. still struggling with coal-mine safety By Ken Ward Jr. February 2, 2013 Story Share CHARLESTON, W.Va. -- West Virginia led the nation in 2012 with seven coal-mining deaths, according to figures from the U.S. Department of Labor's Mine Safety and Health Administration.The fatality count for 2012 was one more than the six West Virginia miners who died on the job in 2011.Nationwide, 19 coal miners were killed in on-the-job accidents last year, down slightly from 21 coal-mining fatalities in 2011. The nation also recorded 17 metal and nonmetal mining deaths in 2012, up from 16 the previous year, according to MSHA data.Across all types of mining, the industry's total fatality count in 2012 was 36, down from 37 in 2011, and half of the 71 who died in 2010, when 29 coal miners died in an explosion at the Upper Big Branch Mine in Raleigh County.Alpha Natural Resources accounted for three of West Virginia's mining deaths last year, and CONSOL Energy accounted for two. The other deaths occurred at mines owned by Coal River Mining LLC and Arch Coal.Kentucky had the second most coal-mining deaths last year, with four. Alabama had two, and Colorado, Illinois, Indiana, Ohio, Tennessee, and Virginia had one each.West Virginia led the nation in coal-mining fatalities in five of the last dozen years. Kentucky led the nation six times during that period, and Utah led once, in 2007, when nine workers died in the disaster at Murray Energy's Crandall Canyon Mine.In West Virginia, the criminal investigation continues into the explosion at Massey's Upper Big Branch Mine. Last month, a former Upper Big Branch Mine superintendent was sentenced to nearly two years in jail for his role in a plot to skirt safety rules and cover up the resulting hazards at the Raleigh County operation where 29 miners died in an April 2010 explosion.U.S. District Judge Irene Berger sentenced Gary May to 21 months in prison, three years of probation and a $20,000 fine for one felony count of conspiracy to thwart the federal government's mine safety efforts.Berger said the sentence should deter anyone in the coal industry from "putting business interests and mining coal and making money ahead of safety."U.S. Attorney Booth Goodwin said his office was pleased with the sentence, and warned that prosecutors in Southern West Virginia will not tolerate criminal violations of mine safety laws. "If you put profits and production ahead of mine safety, you will go to jail," Goodwin said. Goodwin said his office's probe is continuing into a "significant conspiracy" to violate mine safety laws at Massey operations, but declined to say yet if prosecutors believe criminal actions extended into Massey's executive suite or corporate boardroom."We are going to take our investigation where it goes," Goodwin said. "But at this point, I'm not willing to specify how far that conspiracy went at Massey Energy."In the Upper Big Branch probe, May is the third person that Berger has so far sent to jail. A former UBB miner, Thomas Harrah, was sentenced to 10 months in jail after he admitted to faking a foreman's license when he performed key mine safety examinations at the mine between January 2008 and August 2009, and then lied to investigators about his actions.The judge sentenced a former Upper Big Branch security director, Hughie Elbert Stover, to 36 months in jail after Stover was convicted of two felonies: Making a false statement and obstructing the government probe of the mine disaster.And next up in the investigation is a former longtime Massey official, David C. Hughart, who is scheduled to enter a guilty plea in late February to two criminal charges, including taking part in a decade-long scheme involving advance notice of MSHA inspections at various Massey mines. Hughart is also cooperating with investigators.Meanwhile, MSHA is moving forward with some of the more significant regulatory improvements that have been held up during President Obama's first term.Under a rule finalized in January, coal operators whose mines repeatedly violate safety and health standards could more easily be hit with tougher enforcement actions.U.S. Department of Labor officials released the final version of their long-awaited updated rules aimed at reforming the controversial "pattern of violations," or "POV," program at the federal Mine Safety and Health Administration. The rules stop mine operators from using appeals of safety citations to avoid tougher enforcement and do away with MSHA warning letters that give companies additional time to improve before facing tougher enforcement."We think that this final rule will help prevent another tragedy such as occurred at the Upper Big Branch Mine," said MSHA chief Joe Main.Reach Ken Ward Jr. at email@example.com or 304-348-1702. Story Share Story Share Trending Now 1 Man charged after motorcycle pursuit early Sunday 2 Former State Police captain now chief in Winfield 3 Preston County delegate Tony Lewis dies 4 Deer in 8 WV counties found dead from EHD 5 Innerviews: Dual-identity surgeon riding high in horse racing world Patriot move a sign of mountaintop removal's decline Previous Story Pressure builds for Obama to link oil sands pipelines to climate change Next Story


text:
The Darwin Day Roadshow is returning!
NCSE is pleased to offer a free preview (PDF) of Joseph Romm's Climate Change: What Everyone Needs to Know (Oxford University Press, 2016).
On November 14, 2016, the Supreme Court declined (PDF, p. 2) to review COPE et al. v. Kansas State Board of Education et al., thus bringing the case to a decisive end. At issue was Kansas's adoption of the Next Generation Science Standards, which, according to the plaintiffs-appellants, "establish[ed] and endorse[d] a non-theistic religious worldview" in violation of the Constitution.
Ralph J. Cicerone, immediate past president of the National Academy of Sciences, died on November 5, 2016, at the age of 73, according to a memorial notice from the Academy.
With the addition of Steven G. Allen on October 18, 2016, NCSE's Project Steve attained its 1400th signatory.
National Center for Science Education, Inc.
1904 Franklin Street, Suite 600
Oakland, CA 94612
fax: 510-788-7971
For Reporters | Store | Events

subset: commoncrawl


text:
Tricks of the Trade
This book is currently out of print
"Let's put together a book!" It was 1989. The Midwifery Today magazine staff had spent more than two years producing the Tricks of the Trade column, and editor in chief Jan Tritten had a vision: gather all the tricks into a book that would tuck easily into a midwife's birth basket. So we did, and the first Midwifery Today book was on the loose. Over the following several years, the idea of gleaning from the pages of Midwifery Today magazine blossomed into several more books, full of woman-wisdom and experience. In their pages, midwives teach each other about becoming a midwife and what it's like to be one; they tender their best techniques; they talk about homebirth; they share their lives and countless births. It's like sitting around a table with your best friends or staying up all night, talking up a storm. Get in on the circle—you're always welcome at the party!
Table of Contents
- Organizing Your Practice
- Prenatal
- Educating Parents
- Labor (First Stage)
- Birth (Second Stage)
- After the Birth (Third Stage)
- Postpartum
- For the Babies
- Features
- Managing Postpartum Hemorrhage by Daphne Singingtree
- Pitfalls in Prescribing Alternative Remedies by Alison Parra Bastien
- Tear Prevention by Jan Tritten
- Protecting the Upper Tissues by Cathryn Feral
- Inducing Naturally by Alison Osborn
- Nutrition for Two, Preventing Cesarean by Anne Frye
- The Formulary
We owe the creation of Midwifery Today's Tricks of the Trade to the many talented practitioners who took time out of their busy birthing lives to write down these hints for all of us. Most of these tricks have appeared in one form or another in Midwifery Today over six years of publishing. We continue to share tricks regularly in our magazine. We hope as you read and use these you will consider submitting some tips from your practice—whether you work in homebirth, birth centers or a hospital.
When I was a practicing midwife I considered my knowledge to be an invisible bag of tricks. I preferred to empower the birthing mom by letting her birth with minimal interference and simple encouragement. When labor become prolonged or situations occurred, however, I was so glad to have a huge bag of tricks at my disposal. Many situations never turned into crises because a simple technique was successful.
I do want to warn you, however, to be very selective and careful in your practice. Only you can decide if a trick is logical and helpful. These tips are shared with the best intentions. But please remember, any technique we apply to a pregnant and birthing mom and her baby has the potential to be harmful or even dangerous. So please, be careful and scrutinize every choice you make. If it isn't necessary, don't do it. Trust in the mom and baby and their abilities and use these suggestions only as necessary.
— Jan
This book is dedicated to all the midwives past, present and future. Let's keep the flame of with-woman care burning bright.
Tricks of the Trade, Vol. I, paper cover,
8" by 11" magazine format, 54 pages
This title is currently out of print.


text:
My Account / Buy Tickets Download App:
NY Waterway
Nov. 8th - Dec 30th
The Radio City Christmas Spectacular presents an unparalleled Christmas show with universal appeal that lifts the spirits and creates lasting memories. Debuting in 1933 at the iconic Radio City Music Hall, The Radio City Christmas Spectacular has been seen by millions of people through the years and has played in more than 60 cities across North America.
This Christmas season the world famous Rockettes celebrate 86 years of joy, style, inspiration and excitement. This year's show will feature-imaged numbers, beloved favorites and amazing special effects. 'TIS THE SEASON' for the Christmas celebration that you and your family can't afford to miss! NY Waterway ferry is the fastest, most convenient way to get to the show. Our free midtown buses are waiting to take you to your destination.
www.radiocitychristmas.com to order online
Ticketmaster at (866)-858-0007
Radio City Music Hall Box Office
To redeem your FREE round trip ferry tickets present your Ticketmaster voucher to the ticket agent at Port Imperial/Weehawken terminal.
Our friendly representatives are standing by ready to assist you with all your questions and arrangements. No pressure, no hype, just friendly service. Guaranteed!
Just call us at 1.800.533.3779 or email us at email@example.com
All sales are final. No cancellations or refunds are offered.
Customer Relations Hours:
Mon-Fri 7:00am to 7:00pm
Sat/Sun 8:00am to 4:00pm
All Packages include parking and transportation discounts.
Every Your Key to the City package includes a reduced rate on ferry transportation, savings on parking at Port Imperial and the free NY Waterway bus service in midtown and downtown Manhattan. You travel hassle free with more time to enjoy the city.
Please refer to our Privacy Policy for important information on the use of cookies. By continuing to use this website, you agree to this.
For Ferry Info: 800 53 FERRY (800-533-3779)
Corporate Headquarters:
4800 Avenue at Port Imperial
Weehawken, NJ 07086
Send Mail ATTN: Customer Service


text:
GSA Awards FDIC Enterprise-wide IT Support Task Order
September 23, 2004
Contact: Mary Alice Johnson (202) 501-2699
WASHINGTON, DC – The U.S. General Services Administration's (GSA) Federal Technology Service (FTS) has awarded a comprehensive enterprise-wide information technology services support task order for the Federal Deposit Insurance Corporation (FDIC) technology infrastructure.
The performance-based task order, which replaces 36 existing contracts, provides a wide range of IT infrastructure support services including program management; client and help desk support; data center operations and local area network administration; security operations and support; systems engineering and integration; and asset management. This task order will provide a single point of accountability producing innovative, efficient, and cost-effective IT infrastructure support services and will align infrastructure management and support to benefit from industry best practices. Awarded to SRA International, Inc. through GSA's Millennia contract, the task order has a value of more than $300 million over five years, if all options are exercised.
"The award of this complex, integrated IT acquisition exemplifies the expertise and professionalism offered by FTS' Federal Systems Integration and Management Center (FEDSIM)," said FTS Commissioner, Sandra N. Bates. She added, "We are pleased to have been able to manage this acquisition on behalf of FDIC's Division of Information Resources Management and look forward to working with them to help ensure the success of this important project."
FEDSIM offers a wide range of support for planning, developing, acquiring, implementing, maintaining, and managing IT resources and support services. Managing over $1.4 billion in new IT acquisitions in 2003, FEDSIM has a proven track record of developing innovative and award-winning solutions to government IT problems and satisfying requirements for specific IT products and services.
GSA is a centralized federal procurement and property management agency created by Congress to improve government efficiency and help federal agencies better serve the public. It acquires, on behalf of federal agencies, office space, equipment, telecommunications, information technology, supplies, and services. GSA, comprised of 14,000 associates, provides services and solutions for the office operations of over 1 million federal workers located in 8,300 government-owned and leased buildings in 1,600 U.S. communities.


text:
iHerb Customer Reviews
pain relief
Verified Purchase
pain relief
Helps a lot with pain relief. Surprised my daughter with how much it helped a dance injury
Was this review helpful to you?
pain relief
Posted by iHerb Customer on Jan 13, 2012 | Verified Purchase
Helps a lot with pain relief. Surprised my daughter with how much it helped a dance injury
Can't do without it!
Posted by iHerb Customer on Aug 02, 2016 | Verified Purchase
I was recently diagnosed with RA and it has concentrated on my feet and hands. I have digestive issues, so finding something that can relieve the stiffness and pain and NOT upset my stomach is a challenge. My Rheumatologist recommended Turmeric and I tried several different combinations before this one. This is the BEST and if I run out and go a few days without it, I really notice the difference. (My only complaint is that the larger size- 60 tablets is not so frequently in stock, so I have to buy several bottles of the smaller quantity. ) ENTHUSIASTICALLY RECOMMEND.
Turmeric Tablets are great for Headaches
Posted by FogBytheSea on Jul 15, 2014 | Verified Purchase
I take this whenever I feel a headache coming on. They really work for me and I also like the fact that they come in tablet form which I find more convenient for storing in a pill case in my purse. Works great and much safer than nsaids.
Hard to swallow
Posted by iHerb Customer on Apr 05, 2016 | Verified Purchase
Tablets are too large and not easy to swallow. You have to make sure you have plenty of water or else you can choke with the tablet. I prefer capsules, but these are cheaper.
the best antiflamory
Posted by iHerb Customer on Jul 12, 2014 | Verified Purchase
A learn about turmeric in India, it is very very good Supplement and excellent for cooking safe and healthy thanks.
Good contents
Posted by iHerb Customer on Mar 13, 2017 | Verified Purchase
I take this to kill off any future cancer cells in my body as I have had bone marrow cancer approx 3 years ago and I feel good.
Posted by iHerb Customer on Sep 22, 2016 | Verified Purchase
I'm using this for gut health, as maintenance. I have noticed fewer colds/virus'. I feel less rundown. I will continue to take 2tablets a day.
Good Turmeric
Posted by iHerb Customer on Mar 14, 2016 | Verified Purchase
Good form of Turmeric.
Review of Product
Posted by Joyster on Feb 18, 2016 | Verified Purchase
I fell very comfortable in taking this product. It appears to be high quality with excellent ingredients.
Easy to take!
Posted by iHerb Customer on Jul 26, 2017 | Verified Purchase
I have been taking these tablets for well over 1 year now and great!!! Really feel the benefit for my whole body, especially aging joints!
1-10 of 11 total
1 2


text:
A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects
This study has been completed.
Information provided by:
ClinicalTrials.gov Identifier:
First received: June 6, 2006
Last updated: June 21, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
The purpose of this study is to confirm that apricitabine does not induce any clinically significant effect upon electrocardiogram (ECG) parameters at doses consistent with the maximum exposure expected to occur in clinical practice.
|HIV Infections
|Drug: apricitabine
|Phase 1
|Study Type:
|Study Design:
|Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
|Official Title:
|A Double-blind, Placebo-controlled, Positive Controlled, Randomized, Crossover Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects
Resource links provided by NLM:
MedlinePlus related topics: HIV/AIDSU.S. FDA Resources
Further study details as provided by Avexa:
Primary Outcome Measures:
- QTc at individual Day 7 post-dose Tmax as determined by concurrent pharmacokinetic (PK) analysis for apricitabine [ Time Frame: day 7 ]
- The maximum Day 7 QTc increase from baseline observed between 1 to 4 hours post-dose, using time-matched ECG assessments [ Time Frame: day 7 ]
- The average Day 7 QTc observed between 1 to 4 hours post-dose [ Time Frame: day 7 ]
|Study Start Date:
|June 2006
|Study Completion Date:
|August 2006
|Primary Completion Date:
|August 2006 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
|18 Years to 65 Years (Adult)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Inclusion Criteria:
- Healthy male subjects 18 - 65 years of age, inclusive.
- Body mass index (BMI) between 18-30 kg/m2, inclusive, and a total body weight > 50 kg.
- No clinically significant medical history.
- No clinically significant findings on complete physical examination, including blood pressure, pulse rate and 12-lead ECG.
- Normal clinical safety laboratory results at screening.
- Willing and able to sign an informed consent document indicating understanding the purpose of and procedures required for the study and willingness to participate in the study.
- Willing and able to stay in the clinic for the in-patient activities required by the protocol.
Exclusion Criteria:
- Evidence of clinically relevant pathology that could interfere with the study results or put the subject's safety at risk.
- Current or recurrent disease that may affect the action, absorption or disposition of the study treatment, or clinical or laboratory assessments.
- Current or relevant previous history of serious, severe or unstable (acute or progressive) physical or psychiatric illness, any medical disorder requiring treatment or that may make the subject unlikely to fully complete the study, or any condition that presents undue risk from the study treatment or procedures.
- History of febrile illness within the 5 days prior to the first dose.
- Positive Hepatitis B surface antigen, Hepatitis C antibody or HIV test result at screening visit.
- Use of any prescription medication within 7 days or 5 half-lives (whichever is longer) prior to the first dose of trial medication or during the study. As an exception, acetaminophen may be used at doses of ≤ 1 g/day.
- Use of any over-the-counter (OTC) medication within 7 days or 5 half-lives (whichever is longer) prior to or during the study. Herbal supplements (including herbal weight-loss or "metabolism booster" therapies) must be discontinued 28 days prior to the first dose of trial medication.
- Known or suspected intolerance or hypersensitivity to the study drugs, closely related compounds or any of their stated ingredients.
- Subjects with a history of regular alcohol consumption exceeding 14 drinks/week (1 drink = 5 ounces [150 ml] of wine, 12 ounces [360 ml] of beer or 1.5 ounces [45 ml] of hard liquor) or illicit substance abuse within 6 months of screening.
- Positive screen for alcohol or drugs of abuse during screening visit or at study check-in.
- History or evidence of routine use of tobacco or nicotine-containing products in excess of 5 cigarettes per day (or equivalent).
- Participated in a clinical study involving an investigational drug within 30 days or 5 half-lives (whichever is longer) prior to study drug administration.
- Blood donation of one pint or more within 56 days of the start of the study.
- Plasmapheresis or plasma donation within 30 days of the start of the study.
- Single 12-lead ECG demonstrating QTc > 450 msec at screen. A single repeat ECG may be done at the investigator's discretion.
- Any condition that in the opinion of the investigator would complicate or compromise the study, or the well-being of the subject.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00334659
Please refer to this study by its ClinicalTrials.gov identifier: NCT00334659
|United States, Michigan
|Jasper Clinic Inc.
|Kalamazoo, Michigan, United States, 49007
Sponsors and Collaborators
|Study Director:
|Susan W Cox, PhD
More Information
Keywords provided by Avexa:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 21, 2017
|Responsible Party:
|Susan Cox, Avexa
|ClinicalTrials.gov Identifier:
|NCT00334659 History of Changes
|Other Study ID Numbers:
|Study First Received:
|June 6, 2006
|Last Updated:
|June 21, 2011
Keywords provided by Avexa:
HIV-1 Infection
Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
ClinicalTrials.gov processed this record on September 21, 2017